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Fatty acid synthesisWe show that testicular orphan nuclear receptor 4 (TR4) increases the expression of pyruvate car-
boxylase (PC) gene in 3T3-L1 adipocytes by direct binding to a TR4 responsive element in the murine
PC promoter. While TR4 overexpression increased PC activity, oxaloacetate (OAA) and glycerol levels
with enhanced incorporation of 14C from 14C-pyruvate into fatty acids in 3T3-L1 adipocytes, PC
knockdown by short interfering RNA (siRNA) or inhibition of PC activity by phenylacetic acid
(PAA) abolished TR4-enhanced fatty acid synthesis. Moreover, TR4 microRNA reduced PC expression
with decreased fatty acid synthesis in 3T3-L1 adipocytes, suggesting that TR4-mediated enhance-
ment of fatty acid synthesis in adipocytes requires increased expression of PC gene.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Adipose tissue plays a critical role in lipid homeostasis within
the body through lipid storage and mobilization in response to
energy demands. In addition to storing circulating free fatty acids
(FFAs) in the form of triglycerides, adipocytes also endogenously
synthesize fatty acids, contributing up to 20% of fatty acids in adi-
pocyte triglycerides [1]. Alteration of lipid metabolism in adipose
tissue by dysregulated expression of genes involved in lipogenesis
and lipid ﬂux is frequently associated with obesity, insulin
resistance, and diabetes [2,3].
Pyruvate carboxylase (PC) is an enzyme that catalyzes biotin-
and ATP-dependent carboxylation of pyruvate to form oxaloace-
tate (OAA) in mitochondria [4]. In mammals, PC is highly expressed
in adipose tissue. Moreover, expression and activity of the PC gene
is signiﬁcantly increased during adipocyte differentiation, suggest-
ing a lipogenic role of PC in adipocytes [5]. OAA supplies glycerol
required for triglyceride synthesis through glyceroneogenesis [6].In addition, OAA is converted to citrate in mitochondria by conden-
sation with acetyl-CoA and then citrate is transported to the cyto-
plasm, where it is cleaved to form OAA and acetyl-CoA. Acetyl-CoA
is converted to malonyl-CoA and then condensed to long-chain
fatty acyl-CoA by the action of acetyl-CoA carboxylase (ACC) and
fatty acid synthase (FAS). Thus, provision of OAA by PC is essential
for triglyceride accumulation in adipocytes in that it supplies not
only glycerol but also the cytoplasmic acetyl-CoA. A recent study
has reported that Zucker fatty rats (fa/fa) show increased
expression of the PC gene accompanied with other lipogenic genes
in adipose tissue, suggesting that an anaplerotic role of PC in
adipose tissue might be required for the progression of obesity
[7].
Testicular orphan nuclear receptor 4 (TR4) is a member of the
nuclear hormone receptor superfamily and functions as a tran-
scriptional regulator of many signaling pathways [8]. Accumulat-
ing evidences suggest that TR4 is a key regulator of energy
homeostasis via regulation of various genes involved in glucose
and lipid metabolism [9–12]. Accordingly, loss of TR4 in mice
resulted in reduced lipid deposition in liver and white adipose
tissue [9]. Recently, we found that TR4 promotes fatty acid uptake
in 3T3-L1 adipocytes via induction of the FATP1 gene, resulting in
increased lipid accumulation in 3T3-L1 adipocytes [11]. Combining
the facts from the phenotypes of TR4 deﬁcient mice and the
regulatory role of TR4 in lipid metabolism, it is highly possible that
TR4 may also play a role in lipogenesis in adipocytes.
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thesis in adipocytes by using 3T3-L1 cells stably overexpressing
or silencing the TR4 gene. TR4 overexpression increased the
expression of PC gene with increase of fatty acid synthesis. Fur-
thermore, inhibition of PC expression or activity by PC siRNA or
PC speciﬁc inhibitor, phenylacetic acid (PAA), abolished TR4-
enhanced fatty acid synthesis in TR4 overexpressing 3T3-L1 adipo-
cytes. The role of TR4 in PC expression and fatty acid synthesis in
adipocytes was further conﬁrmed by silencing of TR4. Taken
together, we have demonstrated that TR4 is required for de novo
fatty acid synthesis and thus, serves as a novel modulator of lipo-
genesis in adipocytes.
2. Results
2.1. TR4 induces PC expression in adipocytes
In our previous report, we demonstrated that TR4 enhances
lipid accumulation in 3T3-L1 adipocytes via increase of fatty acid
transport [11]. In addition to fatty acid uptake, fatty acid synthesis
plays a key role in lipid accumulation in differentiating adipocytes
[13]. Thus, we were interested to see if TR4 regulates expression of
the genes involved in fatty acid synthesis in 3T3-L1 adipocytes. To
avoid clonal variations, we used pools of stable 3T3-L1 cells
expressing TR4 (3T3-L1-TR4) or the corresponding empty vector
(3T3-L1-C) [11]. We induced differentiation of 2-day post-conﬂuent
3T3-L1 preadipocytes (designated day 0) by the standard protocol
and determined TR4 effect on lipogenic gene expression in day 8
adipocytes. Real-time PCR (RT-qPCR) and Western blot analysis
showed that overexpression of TR4 induced mRNA and protein
expression of the PC, FAS, and ACC genes with highest induction
of PC gene (Fig. 1A and B). However, we could not observe any
effect of TR4 overexpression on the mRNA levels of transcription
factor genes that are important for fatty acid synthesis such as
LXR, SREBP1, and ChREBP in 3T3-L1 adipocytes (Supplementary
Fig. 1). Since the PC gene has been known to facilitate lipid
accumulation in adipocytes via its role of supplying cytosolic
acetyl-CoA which is essential for fatty acid synthesis [14], we
decided to further analyze TR4 effect on PC gene expression to
determine TR4 role in lipogenesis in adipocytes using RT-PCRFig. 1. TR4 enhances PC gene expression in adipocytes. (A and B), The mRNA (A) and prot
respectively in TR4 overexpressing (3T3-L1-TR4) or control 3T3-L1 adipocytes (3T3-L
transiently transfected with TR4 expression plasmid or control plasmid and TR4 effec
⁄⁄P < 0.005, ⁄⁄⁄P < 0.001.)analysis. The PC mRNA level was signiﬁcantly increased about
13-fold in NIH-3T3 cells transiently transfected with TR4, as
compared with control cells transfected with pCDNA3 (Fig. 1C).
Consistently, ex vivo transfection of mouse white adipose tissue
with TR4 resulted in 2.7-fold increase of PC mRNA level (Fig. 1C).
Together, these data suggest that TR4 may regulate PC gene
expression in adipocytes and white adipose tissue.
2.2. TR4 binding to the direct repeat 1 (DR1) element located in the PC
promoter is critical for TR4 induction of the PC promoter activity
We next examined the effect of TR4 on the PC promoter activity
using a luciferase reporter linked to the mouse PC 50 promoter
spanning 699 to +45 bp (pGL3-PC-Luc). Addition of TR4 increased
the transcriptional activity of the PC promoter in both NIH-3T3 and
HEK293T cells in a dose-dependent manner (Fig. 2A).
Sequence analysis revealed that the promoter region of the
mouse PC promoter gene contains a DR1 element (PC-TR4RE)
located at 371 to 359 bp. To determine whether this potential
TR4RE could be recognized by TR4, we performed a gel shift assay.
As shown in Fig. 2B, TR4 could bind to the PC-TR4RE in a dose-
dependent manner. In contrast, the mock-translated control lysate
was unable to form a complex with the PC-TR4RE. The TR4/PC-
TR4RE complex could be abolished by excesses of the unlabeled
PC-TR4RE but not by mutated unlabeled PC-TR4RE. Moreover,
the TR4/PC-TR4RE complex was supershifted by the addition of
an anti-TR4 antibody. To further determine in vivo binding of
TR4 to the PC promoter via PC-TR4RE, we performed a ChIP assay
in control 3T3-L1 cells (3T3-L1-C and 3T3-L1-miR) with TR4 over-
expressed (3T3-L1-TR4) and silenced 3T3-L1 cells (3T3-L1-
TR4miR). As shown in Fig. 2C, qPCR analysis revealed that the PC
promoter region (469 to 222 bp) encompassing PC-TR4RE, but
not the upstream region (2201 to 2000 bp), was ampliﬁed from
3T3-L1 DNA immunoprecipitated with anti-TR4 antibody. Further
recruitment of TR4 to the PC promoter region containing PC-TR4RE
was observed in 3T3-L1-TR4 cells. In contrast, ampliﬁcation of this
PCR product was strongly reduced in 3T3-TR4miR cells. The ChIP
assay was also performed using NIH-3T3 cells transfected with
TR4 expression plasmid and either wild-type (pGL3-PC-Luc) or
mutant PC promoter construct (pGL3-mtPC-Luc) in which TR4REein levels (B) of lipogenic genes were determined by RT-qPCR and Western blotting,
1-C). (C) NIH-3T3 cells or mouse epididymal white adipose tissues (WAT) were
t on PC expression was analyzed 36 h after transfection using RT-PCR. (⁄P < 0.05,
Fig. 2. TR4 binding to the TR4RE site of the PC promoter region is essential for TR4 stimulation of PC promoter activity. (A) TR4 activated PC promoter activity in a dose-
dependent manner. As indicated, the reporter plasmid (pGL3-PC-Luc) was co-transfected with different amounts of TR4 expression plasmid into NIH-3T3 or HEK293T cells.
(⁄⁄P < 0.005, ⁄⁄⁄P < 0.001). (B) Sequence of the putative TR4RE region in the mouse PC promoter (upper panel). Underlined bases indicate mutated base pairs. Gel shift assay
(lower panel) was performed using in vitro translated TR4 and 32P-labeled TR4RE with unlabeled wild type (wt), mutated (mt) TR4RE, or TR4 antibody, as indicated. (C) ChIP
assays of day 6 3T3-L1 adipocytes (3T3-L1-TR4, 3T3-L1-C, 3T3-L1-TR4miR, and 3T3-L1-miR) by using anti-TR4 antibody or normal IgG. ChIP DNA was subjected to RT-qPCR
using primers amplifying the region (371 to 359 bp) that contained the putative TR4RE or 50 upstream region (2201 to 2000 bp). (⁄P < 0.05, ⁄⁄⁄P < 0.001). (D) ChIP
analyses of NIH-3T3 cells transfected with TR4 expression plasmid and pGL3-PC-Luc (TR4 + wtPC pro) or pGL3-mtPC-Luc (TR4 + mtPC pro). (E) HEK293T cells were co-
transfected with TR4 expression plasmid and a luciferase reporter-containing wild-type (pGL3-PC-Luc) or TR4RE mutated mouse PC promoter (pGL3-mtPC-Luc), as indicated.
(⁄P < 0.05, ⁄⁄⁄P < 0.001.)
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promoter construct to NIH-3T3 cells resulted in enhanced PCR
ampliﬁcation of the PC promoter region encompassing PC-TR4RE
(Fig. 2D). In contrast, this enhancement was not observed when
pGL3-PC-Luc was replaced by pGL3-mtPC-Luc. We next examined
the importance of this TR4 binding site for TR4 transcriptional
activation of the PC promoter in NIH-3T3 cells by reporter
gene assay. As shown in Fig. 2E, while TR4 stimulated the
pGL3-PC-Luc promoter activity in a dose-dependent manner,
mutation of TR4RE in the pGL3-PC-Luc abolished TR4 effect on
the PC promoter activity. Together, these data strongly suggest that
TR4 induces the PC promoter activity via binding to TR4RE located
in the PC promoter.
2.3. PC mediates TR4 stimulation of fatty acid synthesis in 3T3-L1
adipocytes
Since TR4 induced PC expression in 3T3-L1 adipocytes, we mea-
sured the PC activity to determine whether TR4 overexpression
enhances PC activity in 3T3-L1 adipocytes. PC activity in 3T3-L1-
TR4 adipocytes was increased by 1.8-fold at day 4 and 1.6-fold at
day 8 as compared with control 3T3-L1 adipocytes (3T3-L1-C)
(Fig. 3A, left panel). Furthermore, the cellular contents of OAA in
3T3-L1-TR4 adipocytes were also higher than those observed in
3T3-L1-C adipocytes on days 4 and 8 (Fig. 3A, right panel). Because
PC is implicated in de novo fatty acid synthesis in adipocytes [14],
we used PAA, PC-speciﬁc inhibitor, to investigate the role of PC in
TR4-induced fatty acid synthesis in 3T3-L1 adipocytes. PAA has
been known to inhibit PC activity via conversion into phenylace-tyl-CoA which in turn competes with acetyl-CoA for PC [15]. As
expected, addition of 2.5 mM PAA into day 6 3T3-L1-TR4 adipo-
cytes signiﬁcantly reduced TR4-induced OAA and glycerol levels
with concomitant reduction of PC activity (Fig. 3B). We next added
0.5 lCi 14C-labeled pyruvate to day 6 3T3-L1 adipocytes and incu-
bated the cells for 12 h to determine whether TR4 could enhance
fatty acid synthesis in adipocytes. The radioactive carbon of 14C-
pyruvate was incorporated into fatty acids both in 3T3-L1-C and
3T3-L1-TR4 adipocytes (Fig. 3C). Moreover, 3T3-L1-TR4 adipocytes
showed about 2.3-fold increase of fatty acid synthesis relative to
that of 3T3-L1-C adipocytes. When 3T3-L1-TR4 adipocytes were
incubated with 2.5 mM PAA for 24 h, PAA abolished TR4 enhance-
ment of 14C-incorporation into newly synthesized fatty acids.
However, PAA did not affect TR4-enhanced expression of lipogenic
genes such as PC, FAS, ACC, and PEPCK-C in 3T3-L1 adipocytes,
indicating that PAA reduces FAA synthesis and glycerol levels by
inhibition of PC activity, and not by inhibition of gene expression
(Supplementary Fig. 2). Next, we analyzed the effect of PAA on lipid
accumulation in day 8 3T3-L1 adipocytes by using Oil Red O stain-
ing. As expected, adipocyte differentiation in the presence of PAA
reduced lipid accumulation in both control and 3T3-L1-TR4
adipocytes (Fig. 3D). Furthermore, PAA inhibited TR4-enhanced
lipid accumulation, suggesting that TR4 might enhance lipid accu-
mulation during adipogenesis in part by upregulation of PC
activity.
To further conﬁrm the essential role of PC in TR4 enhancement
of fatty acid synthesis, PC expression in 3T3-L1-TR4 adipocytes was
inhibited by PC-speciﬁc siRNAs targeting different regions of PC
gene. We ﬁrst determined mRNA levels of FAS and ACC genes
Fig. 3. TR4 elevates PC activity, OAA and glycerol levels and de novo fatty acid synthesis in 3T3-L1 adipocytes. (A) 3T3-L1 preadipocytes (3T3-L1-TR4 and 3T3-L1-C) were
differentiated and PC activity (left panel) and OAA level (right panel) were determined on the indicated days. PC activity and OAA levels were measured in total cell lysate as
described in ‘‘Section 4’’. (B) Day 6 adipocytes (3T3-L1-TR4 or 3T3-L1-C) were treated with vehicle or 2.5 mM PAA for 24 h and PC activity (left panel), OAA (middle panel) and
glycerol levels (right panel) were then measured. (C) Day 6 3T3-L1 adipocytes were incubated with 0.5 lCi 14C-pyruvate for 12 h in the absence or presence of 2.5 mM PAA
and the incorporation of radioactive carbon into the fatty acids was then measured. (D) After 3 day induction of differentiation, cells were continuously treated with 2.5 mM
PAA and then stained with Oil Red O on day 8 to determine PC effect on TR4-enahnced lipid accumulation during adipocyte differentiation. (⁄⁄P < 0.005, ⁄⁄⁄P < 0.001).
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test whether either of PC siRNAs may nonspeciﬁcally affect mRNA
levels of these genes. As shown in Fig. 4A, expression of PC gene
but none of other lipogenic genes (FAS and ACC) was signiﬁcantly
reduced by either of PC siRNAs. In addition, PC silencing by these
PC siRNAs reduced the enhancing effect of TR4 on PC activity,
OAA and glycerol levels (Fig. 4B). Consistently, addition of PC
siRNA1 dramatically decreased TR4-enhanced de novo fatty acid
synthesis and lipid accumulation in day 6 and 8 3T3-L1-TR4
adipocytes, respectively (Fig. 4C and D).
2.4. TR4 knockdown inhibits PC expression and fatty acid synthesis in
3T3-L1 adipocytes
We next assessed the effect of TR4 knockdown on PC expression
and activity using pools of stable 3T3-L1 adipocytes expressing
TR4-speciﬁc microRNA (3T3-L1-TR4miR). RT-qPCR analysis
showed that silencing TR4 in 3T3-L1 adipocytes signiﬁcantly
decreases the PC mRNA levels but only mildly reduces FAS and
ACC expression on day 6 (Fig. 5A). Furthermore, TR4 knockdown
resulted in reduced PC activity and OAA level in day 6 3T3-L1 adi-
pocytes by 50% and 70%, respectively, relative to 3T3-L1 adipocytes
stably expressing control microRNA (3T3-L1-miR) (Fig. 5B and C).
Since silencing of TR4 suppressed PC expression and activity in
3T3-L1 adipocytes, we analyzed this silencing effect of TR4 on fatty
acid synthesis by measuring incorporation of radioactive carbon
from 14C-pyruvate into fatty acids in day 6 3T3-L1-TR4miR adipo-cytes. Consistent with reduced PC activity and OAA level in 3T3-L1-
TR4miR adipocytes, TR4 knockdown in 3T3-L1 adipocytes
decreased fatty acid synthesis by 60%, as compared with control
adipocytes (3T3-L1-miR) (Fig. 5D), suggesting that TR4 is essential
for de novo fatty acid synthesis in adipocytes.3. Discussion
De novo fatty acid synthesis in addition to fatty acid uptake
is known to contribute to lipid accumulation during adipocyte
differentiation [13,16]. In this study, we showed that TR4
enhanced fatty acid biosynthesis in 3T3-L1 adipocytes by induc-
ing the PC expression. Using gel shift, ChIP, and reporter gene
assays, we showed that TR4 induces PC expression via a newly
identiﬁed TR4RE in the mouse PC promoter. Moreover, TR4
knockdown, pharmacological inhibition of PC activity or PC
silencing reduces TR4-induced fatty acid synthesis and lipid
accumulation.
A previous study had shown that PPARc also induces PC expres-
sion in 3T3-L1 cells, and TR4RE, previously known as PPRE, is
important for enhancing the effect of rosiglitazone on PPARc-
induced PC promoter activity [17]. Furthermore, several studies
show that same/similar ligands, including thiazolidinedione
(TZD), activate TR4 and PPARc [12]. Therefore, TZD may regulate
PC expression not only via PPARc, but also via TR4. Thus, the
relative levels of TR4 and PPARc may determine the effect of TZD
Fig. 4. Silencing of PC gene reduced TR4 stimulation of de novo fatty acid synthesis in 3T3-L1 adipocytes. (A) After 72 h transfection of PC siRNA1, 2 or scrambled siRNA,
silencing effect of PC gene on the expression of FAS and ACC genes in day 6 3T3-L1 adipocytes was analyzed by RT-qPCR. (⁄P < 0.05) (B) Effect of PC siRNAs on PC activity
(upper panel), OAA (middle panel) and glycerol levels (lower panel) were measured in day 6 3T3-L1 adipocytes (3T3-L1-TR4 or 3T3-L1-C). (C) Day 6 3T3-L1 adipocytes were
incubated with 0.5 lCi 14C-pyruvate for 12 h and the incorporation of radioactive carbon into the fatty acids was then measured to determine the PC silencing effect on TR4-
enhanced lipogenesis. (D) 3T3-L1 adipocytes were stained with Oil Red O on day 8 to determine the PC silencing effect on TR4-enhanced lipid accumulation during adipocyte
differentiation. (⁄P < 0.05.)
S.-S. Park et al. / FEBS Letters 588 (2014) 3947–3953 3951on PC expression in adipocytes. Consistent with this possibility,
maximum expression of TR4 and PPARc was observed in WAT at
zeitgeber time 4 and 16, respectively [18]. However, further stud-
ies are necessary to elucidate how TZD uses these two receptors to
regulate the expression of metabolic genes such as PC.
In adipocytes, PC plays a lipogenic role since OAA is essential for
constant supply of phosphoenolpyruvate for the conversion of
glycerol and acetyl-CoA for the fatty acid synthesis, respectively.
In our study, increased expression and activity of PC in TR4 over-
expressing 3T3-L1 adipocytes coincided with the elevation of fatty
acid synthesis and glycerol levels. In addition, similar to the fold
increase of PC expression and activity, TR4 overexpression also
resulted in increase of OAA content in 3T3-L1 adipocytes, suggest-
ing that the TR4-induced increase of OAA level facilitates fatty acid
synthesis by providing available acetyl-CoA, and glyceroneogenesis
by phosphoenolpyruvate in adipocytes.
Various lipogenic enzymes are involved in fatty acid synthesis
and glycerogenesis in adipocytes [19]. In our study, TR4 overex-
pression in 3T3-L1 adipocytes resulted in increased mRNA levels
of FAS and ACC, concomitant with the induction of PC gene. Fur-
thermore, a previous study showed that TR4 regulates the hepatic
expression of PEPCK-C gene, which is important for glycerogenesis
in adipocytes. Therefore, PEPCK-C, FAS, and ACC might have a role
in TR4-mediated increase of glycerol level and fatty acid synthesis
in adipocytes. However, the addition of PAA, a PC speciﬁc inhibitor,
into TR4 overexpressing 3T3-L1 adipocytes abolished the TR4promoting effect on glycerol level and 14C incorporation of pyru-
vate into newly synthesized fatty acids without affecting PEPCK-
C, FAS, and ACC expression. Consistently, knockdown of PC gene
by PC siRNAs in TR4 overexpressing 3T3-L1 adipocytes selectively
reduced PC mRNA level without affecting mRNA levels of FAS or
ACC and abolished TR4-induced fatty acid synthesis. Although
the partial contribution of FAS and ACC to TR4-mediated fatty acid
synthesis could not be ruled out, our results strongly suggest that
PC is an essential component contributing to TR4 effect on fatty
acid synthesis in 3T3-L1 adipocytes. The signiﬁcance of TR4 on
PC expression and fatty acid synthesis in 3T3-L1 adipocytes was
further supported by TR4 knockdown, in which PC mRNA levels
were reduced with decrease of fatty acid synthesis.
Adipocytes maintain energy homeostasis through a dynamic
equilibrium between the uptake and release of fatty acids in
response to energy demand [19]. In addition, adipocytes perform
de novo fatty acid synthesis, which accounts for about 20% of the
triglyceride levels in adipocytes and is critical for maintaining total
body fatty acid synthesis in cooperation with the liver, which is
another major organ for the synthesis and storage of fatty acids
[20]. Because TR4 increases fatty acid uptake and synthesis in adi-
pocytes, it is possible that it plays a key role in the control of total
body fatty acid synthesis and circulating FFA levels, which are
essential for energy homeostasis. However, to gain an insight into
the systematic role of TR4 in energy homeostasis, further study of
its role in hepatic lipogenesis and fatty acid oxidation is required.
Fig. 5. Silencing of TR4 reduced de novo fatty acid synthesis with decreased PC expression in 3T3-L1 adipocytes. (A) Total RNAs were prepared from day 6 3T3-L1 adipocytes
(3T3-L1-TR4miR or 3T3-L1-miR) and the mRNA levels of TR4 and lipogenic genes were determined by RT-qPCR. (B and C) TR4 knockdown inhibits PC activity and OAA level in
3T3-L1 adipocytes. 3T3-L1 cells were differentiated for 6 days and PC activity (B) and OAA level (C) were measured as described in ‘‘Section 4’’. (D) Day 6 3T3-L1 adipocytes
(3T3-L1-TR4miR or 3T3-L1-miR) were incubated with 0.5 lCi 14C-pyruvate for 12 h and the incorporation of radioactive carbon into the fatty acids was then measured.
(⁄P < 0.05, ⁄⁄P < 0.005.)
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by adipose tissue dysfunction associated with insulin resistance,
which causes the onset and progression of type 2 diabetes [2].
TR4 deﬁcient mice exhibit reduced fat mass and circulating FFA
levels with improved insulin sensitivity [9], suggesting that TR4
may contribute to the development of insulin resistance and type
2 diabetes. However, we cannot rule out the possibility that TR4
functions as an insulin sensitizer. Because TR4 facilitates FFA
uptake into adipocytes, it may reduce the risk of FFA incorporation
into the muscle and liver, thereby reducing insulin resistance.
However, further studies are required to clearly deﬁne the role of
TR4 in insulin resistance and type 2 diabetes.
In summary, we demonstrated that TR4 promotes lipogenesis in
3T3-L1 adipocytes through regulation of PC expression. Inhibition
of PC activity or expression leads to impairment in TR4-enhanced
de novo fatty acid synthesis.4. Materials and methods
4.1. Plasmids, transfection and reporter gene and gel shift assays
See Supplementary data.
4.2. Animals, cell culture, differentiation, and Oil Red O staining
See Supplementary data.
4.3. Determination of gene expression
See Supplementary data.
4.4. Western blotting
See Supplementary data.4.5. Chromatin immunoprecipitation (ChIP) assay
See Supplementary data.
4.6. De novo fatty acid synthesis, pyruvate carboxylase activity, OAA
and glycerol levels
See Supplementary data.
4.7. Statistical analysis
Statistical analysis was performed using Student’s t test. All
data are presented as means ± S.D. All experiments were per-
formed in triplicate.
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